We aimed to evaluate oncological and functional outcomes of index lesion HIFU ablation with Focal-One®.
We prospectively assessed treatment-naïve men with localized prostate cancer between 2017 and 2019.
We aimed to evaluate oncological and functional outcomes of index lesion HIFU ablation with Focal-One®.
We prospectively assessed treatment-naïve men with localized prostate cancer between 2017 and 2019.